Scholars@Duke publication: Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure

Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure

Publication , Conference

Pleger, ST; Most, P; Boucher, M; Soltys, S; Chuprun, JK; Pleger, W; Lymperopoulos, A; Gao, E; Remppis, A; Eckhart, AD; Rabinowitz, JE; Koch, WJ

Published in: CIRCULATION

2006

CIRCULATION

1524-4539

0009-7322

2006

114

49 / 49

APA

Chicago

ICMJE

MLA

NLM

Pleger, S. T., Most, P., Boucher, M., Soltys, S., Chuprun, J. K., Pleger, W., … Koch, W. J. (2006). Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure. In CIRCULATION (Vol. 114, pp. 49–49).

Pleger, Sven T., Patrick Most, Matthieu Boucher, Stephen Soltys, J. K. Chuprun, Wiebke Pleger, Anastasius Lymperopoulos, et al. “Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure.” In CIRCULATION, 114:49–49, 2006.

Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, et al. Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure. In: CIRCULATION. 2006. p. 49–49.

Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, Lymperopoulos A, Gao E, Remppis A, Eckhart AD, Rabinowitz JE, Koch WJ. Long-term cardioselective S100A1 gene therapy improves cardiac function in heart failure. CIRCULATION. 2006. p. 49–49.

CIRCULATION

1524-4539

0009-7322

2006

114

49 / 49